Prostate Cancer - Results from #24040

Presenting treatment options to men with clinically localized prostate cancer: The acceptability of active surveillance/monitoring - Abstract January 26, 2013

Improving the communication of benefits and harms of treatment strategies: Decision AIDS for localized prostate cancer treatment decisions - Abstract January 26, 2013

Active surveillance: The Canadian experience with an "inclusive approach" - Abstract January 26, 2013

Quality of life in men undergoing active surveillance for localized prostate cancer - Abstract January 26, 2013

Detection rate of clinically insignificant prostate cancer increases with repeat prostate biopsies - Abstract January 26, 2013

Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer - Abstract January 26, 2013

Guideline-discordant androgen deprivation therapy in localized prostate cancer: Patterns of use in the medicare population and cost implications - Abstract January 25, 2013

Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer - Abstract January 25, 2013

Results from the Scandinavian Prostate Cancer Group Trial Number 4: A randomized controlled trial of radical prostatectomy versus watchful waiting - Abstract January 25, 2013

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence - Abstract January 25, 2013

Use of immunohistochemistry in routine workup of prostate needle biopsies - Abstract January 25, 2013

Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0T in the detection of prostate cancer: Strength and weaknesses - Abstract January 25, 2013

Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: A prospective single cohort study - Abstract January 25, 2013

Personal epigentic "signatures" found consistent in prostate cancer patient metastases January 24, 2013

What is the risk posed by prostate cancer? - Abstract January 24, 2013

Active surveillance for prostate cancer: An underutilized opportunity for reducing harm - Abstract January 24, 2013

Overview of randomized controlled treatment trials for clinically localized prostate cancer: Implications for active surveillance and the United States Preventative Task Force report on screening - Abstract January 24, 2013

Temporal changes in the pathologic assessment of prostate cancer - Abstract January 24, 2013

Temporal changes in the clinical approach to diagnosing prostate cancer - Abstract January 24, 2013

The Prostate Cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically Loca January 24, 2013

Page 1203 of 1438